Endo scraps $190M deal for pharma firm
February 28, 2019 at 13:17 PM EST
The company blamed the collapse on delays in getting regulatory approval for the deal in India.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.